BE alleviates cognitive and motor impairments by decreasing mitochondria reactive oxygen species production (He et al., 2009) and inhibiting the TLR4/MyD88/NF-κB signaling pathway in CCH rats (Song et al., 2024; Liu et al., 2007). The gene discussed is NFKB1; the disease is columnar cell hyperplasia of the breast.